Unbridled and concentrated financial incentive might be a driver of economic activity, but it produces a ripple effect that can…
Ultimately, the best use of an individual’s resources is perpetuating that individual’s existence. And whilst that might seem a little…
Over the last few years dementia as an illness has come out of the shadows. We recognise it more openly…
Impact investing takes into consideration both financial return and social or environmental impact. Profit matters as much in the impact…
ABOUT TOM SPEECHLEY
Tom Speechley is a healthcare start-up founder and investor. His primary focus is on consumer-driven health solutions, particularly within life sciences and longevity, and he co-founded SX2 to pursue these interests. Tom was an early mover in the medicinal cannabis and psychedelic medicine industry and co-founded JMCC Group to create organic products with pharmaceutical standards including an innovative medicinal cannabis nano-spray and organic psilocybin for mental health treatments. He is also interested in digital health and the challenge of applying technology to positive behavioral change. His most recent start-up has developed an AI to help individuals avoid chronic illness.
Tom initially trained and worked as a corporate lawyer in London and New York before a decade in emerging market private equity and venture capital. He has written and spoken widely on finance, investing and healthcare and guest lectured at a number of leading universities in the United States. He has been a featured speaker at the World Economic Forum in Davos, the United Nations, the International Economic Forum of the Americas and the Annual Meeting of the Inter-American Development Bank. He is the author of two books on acquisition finance and coded a series of educational software programs that were among the first used in the UK’s national curriculum on computer studies.
Tom has sat on a number corporate and not-for profit boards including the Emerging Markets Private Equity Association and Junior Achievement Worldwide. He has been a senior advisor to Endeavor.org and is a Fellow of the Royal Society of Arts in the United Kingdom.
“There is no better use of humankind’s resources than perpetuating its existence”
Tom Speechley
One of the main issues for a buyer making an acquisition is how to finance it
Acquisition Finance considers the commercial factors that influence the choice of finance and analyses the most common forms of debt and equity finance.
Offering in depth expert advice it provides a full picture for each scenario of the transaction structure and process from the initial commercial stages, to the structuring aspects, due diligence process, the legal documentation process (including a detailed look at the various legal documents required), to funding and completion.
WE INVEST IN THE BUSINESS OF HUMAN CARE
SX2 Ventures supports innovation and long-term value creation in the human care sector, with a focus on life sciences, longevity, specialized care and emerging market health care solutions